+

WO1990011756A1 - Systeme vitre a liberation lente - Google Patents

Systeme vitre a liberation lente Download PDF

Info

Publication number
WO1990011756A1
WO1990011756A1 PCT/GB1990/000497 GB9000497W WO9011756A1 WO 1990011756 A1 WO1990011756 A1 WO 1990011756A1 GB 9000497 W GB9000497 W GB 9000497W WO 9011756 A1 WO9011756 A1 WO 9011756A1
Authority
WO
WIPO (PCT)
Prior art keywords
glass
active agent
release
water soluble
vitreous
Prior art date
Application number
PCT/GB1990/000497
Other languages
English (en)
Inventor
James Lewis Wardell
John Alaister Duffy
Original Assignee
Aberdeen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908273A external-priority patent/GB8908273D0/en
Priority claimed from GB898909843A external-priority patent/GB8909843D0/en
Application filed by Aberdeen University filed Critical Aberdeen University
Publication of WO1990011756A1 publication Critical patent/WO1990011756A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C3/00—Glass compositions
    • C03C3/12—Silica-free oxide glass compositions
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0035—Compositions for glass with special properties for soluble glass for controlled release of a compound incorporated in said glass

Definitions

  • the present invention relates to slow-release vitreous systems particularly for the release of biologically active materials to an aqueous environment of use over a predetermined time period.
  • Slow-release systems are well known in the art but tend to be specialised becaused of their inherent expense.
  • Slow-release systems are for example used in the pharmaceutical industry for the administration of biologically active agents to a patient over a predetermined time span at a constant or varying rate depending upon the circumstances.
  • Other slow-release systems are known for other purposes, but all suffer from the inherent expense or lack of flexibility of the slow-release vehicle.
  • Glass is a relatively cheap material, and the glasses which are water soluble are known. Indeed phosphate glasses have been used to release inorganic substances which are thermostable since the softening point of
  • phosphate glasses is for example 400 - 500°C. These phosphate glasses have a widely varying dissolution rate depending upon the precise constitution of the watersoluble glass chosen and are hence able to transmit inorganic salts to an environment of use over a predetermined time period.
  • Low melting point water soluble glasses for example the acetate glasses have been described in The Journal of the American Ceramic Society Vol 52, No. 4 April 1969 Pages 224-225. Further nitrate glasses have been described, as such, in the Journal of The Chemical Society 1969 pages 2398 et seq. It has not however been appreciated that the combination of the low softening point of the acetate and other carboxylates and nitrate type glasses combined with their variable water solubility provides an excellent slow release vehicle for heat-sensitive substances, such as biologically active substances, to an aqueous environment of use.
  • GB-A-2,182,034 discloses a vitreous system in which organic materials are incorporated in a water soluble glass by forming a sintered porous body and filling the same with an organic material in liquid form. This disclosure teaches against incorporating organic materials directly into the glass.
  • a slow release vitreous system comprising a water soluble glass having a softening point of less
  • glass describes amorphous material derived for example from carboxylates and nitrates.
  • the active agents which can be biologically active or nonbiologically active, need be stable only to the temperature of the softening point of the glass (see Table 1) . This illustrates the advantages of these glasses: compounds with low decomposition temperatures can be safely entrapped or dissolved with little decomposition.
  • the water soluble glass is a carboxylate, nitrate, sulphate or bisulphate glass having a low softening point, e.g.
  • the glass may be selected from a compound of the formula
  • R 1 and R2 are the same or different and are selected from
  • x has a value of 1 - 3;
  • R 1 and M2 are the same or different and are selected from H, an alkali metal or an alkaline earth metals or a chemically appropriate metal such as lead or zinc.
  • R 1 and M2 are the same or different and are selected from H, an alkali metal or an alkaline earth metals or a chemically appropriate metal such as lead or zinc.
  • M 1 and M2 are lithium, sodium, potassium, calcium, lead or zinc.
  • the glass selected is made from either a single salt or a mixture of salts or a mixture of salts and acids having general formula
  • M 1 , M2, M3... are the same or different and are selected from H, alkali metals or alkaline earth metals or a chemically appropriate metal such as zinc
  • a 1, A , A3 ... are the same or different and are selected from carboxylates preferably chiral carboxylates, such as tartrates nitrate, sulphate or bisulphate; wherein a, b, c ...
  • the invention is further characterised by a method for the production of a slow-release system which method comprises;
  • the glass dissolves to release the active agent over a predetermined time period.
  • the glasses as just described may be coated with a coating material to further modify the slow-release rate of the active agent to the environment of use.
  • the shape and geometry of the water soluble glass may also be adjusted to alter the release rates.
  • the coating material as just described may be a phosphate glass or any selected polymeric material so chosen as to give a desired rate of agent release (see Table 2 below) .
  • the geometry of the system in accordance with the present invention is important. It will be appreciated that the larger the system particle, the smaller the total surface area and hence the slower the release rate in aqueous environment of use. Thus physically relatively large slow-release systems in accordance with the present invention will release the active agent to the environment of use slower than small particles. Thus the constant release rate to an environment of use can be achieved over a long time period by not only selecting the materials from which the release systems are made, but also by altering the relative particle sizes in a mixture applied to an environment of use.
  • the geometry of the slow-release system in accordance " with the present invention may be configured to adjust the output rate of the active agent to an environment of use by altering the rate at which readily soluble glass is exposed for dissolution.
  • the geometry of the slow-release system in accordance " with the present invention may be configured to adjust the output rate of the active agent to an environment of use by altering the rate at which readily soluble glass is exposed for dissolution.
  • a multi-layer system may be achieved by providing a central core of the water soluble glass in accordance with the present invention, overlaid by, for example, a coating of a phosphate glass.
  • the relative diameter of the central core which need not be uniform throughout its length, can be adjusted to provide a desired predetermined dissolution rate.
  • the active agents in accordance with the present invention may for example be pharmaceutically active agents such as hormones and amino-acids, for administration to agriculturally significant animals for example to ruminants.
  • the active agents may be any suitable pharmaceutical agent such as an antibiotic which can be administered to a patient for slow-release.
  • slow-release systems of the present invention can be provided with pheromones which can be utilized to attract specific insects to a specific site.
  • the pheromones can be specific to an insect which is a pest on a particular crop. Tomatoes for example can be cleared of insect pests in a closed tomato growing area without application of toxic materials to the plants themselves. Since pheromones are specific to insects of a particular sex as well as a particular type, it is also possible to separate males and females of a particular species by this method.
  • fertilizers are formed with nitrogen, phosphorus, and potassium for administration to a crop in a seed bed preferably in a single pass operation.
  • the slow-release systems in accordance with the present invention of this type may also include insecticides, fungicides, or other pesticides in general which act to protect the crop during its growing season, (about three or four months), without the necessity for regular spraying.
  • slow-release systems in accordance of this type will be incoporated into the seed bed at the same time as the seed are sown thereby providing long term protection from pest attack as well as fertilization throughout its growing period.
  • the invention is also suitable for the slow-release of descaling agents for pipes and boilers and for the slow-release of bactericidal agents to water storage systems for the prevention, for example, of Leqionella .
  • the systems in accordance with the present invention may also be utilized as wood preservatives for in situ applications.
  • Carboxylate glasses were formed by standard methods to have the following consitution as shown in Table 1.
  • a dissolution rate could be adjusted to be between 24 minutes and 70 days. Since the dissolution rate of the acetate glasses is faster than that of the phosphate glasses in general it will be noted that the slow-release system can be adjusted to release its bolus within any desired time frame. Further by altering the relative geometry of the coating and the core it is possible to release more or less active agent to the enviroment of use over a predetermined portion of the time frame.
  • the invention therefore comprehends not only a slow-release system and a method for the production thereof, but a method of administering an active agent to an environment of use, said enviroment of use being agricultural, veterinary, human or industrial.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un système vitré à libération lente, comprenant un verre soluble dans l'eau ayant un point de ramollissement inférieur à 320°C, et de préférence inférieur à 200°C. Dans ledit verre soluble dans l'eau, s'est dissous ou mélangés avec un agent actif tel qu'un produit pharmaceutique stable au point de fusion du verre, et se libérant dans un environnement aqueux utilisé pendant une période de temps prédéterminé.
PCT/GB1990/000497 1989-04-12 1990-04-03 Systeme vitre a liberation lente WO1990011756A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898908273A GB8908273D0 (en) 1989-04-12 1989-04-12 Slow release vitreous systems
GB8908273.9 1989-04-12
GB898909843A GB8909843D0 (en) 1989-04-28 1989-04-28 Slow release vitreous systems
GB8909843.8 1989-04-28

Publications (1)

Publication Number Publication Date
WO1990011756A1 true WO1990011756A1 (fr) 1990-10-18

Family

ID=26295205

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1990/000497 WO1990011756A1 (fr) 1989-04-12 1990-04-03 Systeme vitre a liberation lente

Country Status (2)

Country Link
AU (1) AU5414990A (fr)
WO (1) WO1990011756A1 (fr)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003978A1 (fr) * 1994-08-04 1996-02-15 Quadrant Holdings Cambridge Limited Systemes d'administration de substances solides, pour la liberation controlee de molecules incorporees dans ces substances et procedes de fabrication de ces systemes
US5998315A (en) * 1994-08-02 1999-12-07 Morgan Crucible Company Plc Strontium aluminate inorganic fibers
US6102896A (en) * 1999-09-08 2000-08-15 Cambridge Biostability Limited Disposable injector device
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6623762B2 (en) 2001-02-16 2003-09-23 Cambridge Biostability Ltd. Composition and method for controlled release injections
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6861381B1 (en) 1999-09-10 2005-03-01 The Morgan Crucible Company Plc High temperature resistant saline soluble fibres
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US6987076B1 (en) 1998-09-15 2006-01-17 The Morgan Crucible Company Plc Bonded fibrous materials
US7097827B2 (en) 1995-04-14 2006-08-29 Inhale Therapeutic Systems, Inc. Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments
US7153796B2 (en) 2002-01-04 2006-12-26 The Morgan Crucible Company Plc Saline soluble inorganic fibres
US7259118B2 (en) 1992-01-17 2007-08-21 The Morgan Crucible Company Plc Saline soluble inorganic fibers
US7300919B2 (en) 1992-09-29 2007-11-27 Nektar Therapeutics Pulmonary delivery of active fragments of parathyroid hormone
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US7521069B2 (en) 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin
US7628978B2 (en) 1997-09-29 2009-12-08 Novartis Pharma Ag Stabilized preparations for use in metered dose inhalers
WO2011048379A2 (fr) 2009-10-21 2011-04-28 Innovata Limited Composition
WO2012159632A1 (fr) * 2011-05-26 2012-11-29 Vestergaard Frandsen Sa Verre fritté destiné à la libération de nutriments ou d'autres agents
US8486439B2 (en) 2007-03-01 2013-07-16 Bioneedle Technologies Group B.V. Parenteral formulation
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US8883830B2 (en) 2003-06-20 2014-11-11 Afgin Pharma LLC. Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent
WO2022237993A1 (fr) * 2021-05-14 2022-11-17 Bimeda Animal Health Limited Article de type bolus soluble dans l'eau ou dispersible dans l'eau contenant du bromoforme
WO2022237992A1 (fr) * 2021-05-14 2022-11-17 Bimeda Animal Health Limited Bolus rumen en verre soluble dans l'eau

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649551A (en) * 1970-09-08 1972-03-14 Corning Glass Works Glassy acetate material
EP0009338A1 (fr) * 1978-09-26 1980-04-02 International Standard Electric Corporation Composition de verre
FR2521835A1 (fr) * 1982-02-23 1983-08-26 Univ Leeds Ind Service Ltd Articles en verre soluble dans l'eau, leur fabrication et leur utilisation pour le traitement des ruminants
SU1351978A1 (ru) * 1986-02-12 1987-11-15 Уральский политехнический институт им.С.М.Кирова Легкоплавкое стекло

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649551A (en) * 1970-09-08 1972-03-14 Corning Glass Works Glassy acetate material
EP0009338A1 (fr) * 1978-09-26 1980-04-02 International Standard Electric Corporation Composition de verre
FR2521835A1 (fr) * 1982-02-23 1983-08-26 Univ Leeds Ind Service Ltd Articles en verre soluble dans l'eau, leur fabrication et leur utilisation pour le traitement des ruminants
SU1351978A1 (ru) * 1986-02-12 1987-11-15 Уральский политехнический институт им.С.М.Кирова Легкоплавкое стекло

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Vol. 108, 1988 (Columbus, Ohio, US) see page 322* Abstract No. 61225x, & SU, A, 1351978 (Ural Polytechnic Institute) 15 November 1987* *
Glass Technology, Vol. 30, No. 5, October 1989 (Sheffield, GB) J.A. BLAIR et al.: "Acetate Glasses for the Slow Release of Thermally Unstable Materials", pages 190-191 *

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259118B2 (en) 1992-01-17 2007-08-21 The Morgan Crucible Company Plc Saline soluble inorganic fibers
US7300919B2 (en) 1992-09-29 2007-11-27 Nektar Therapeutics Pulmonary delivery of active fragments of parathyroid hormone
US7521069B2 (en) 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin
US5998315A (en) * 1994-08-02 1999-12-07 Morgan Crucible Company Plc Strontium aluminate inorganic fibers
WO1996003978A1 (fr) * 1994-08-04 1996-02-15 Quadrant Holdings Cambridge Limited Systemes d'administration de substances solides, pour la liberation controlee de molecules incorporees dans ces substances et procedes de fabrication de ces systemes
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
EP0773781A1 (fr) 1994-08-04 1997-05-21 Quadrant Holdings Cambridge Limited Systemes d'administration de substances solides, pour la liberation controlee de molecules incorporees dans ces substances et procedes de fabrication de ces systemes
AU688557B2 (en) * 1994-08-04 1998-03-12 Quadrant Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6811792B2 (en) 1994-12-02 2004-11-02 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US6565871B2 (en) 1994-12-02 2003-05-20 Elan Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US7056495B2 (en) 1994-12-02 2006-06-06 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6331310B1 (en) 1994-12-02 2001-12-18 Quadrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6893657B2 (en) 1994-12-02 2005-05-17 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US7097827B2 (en) 1995-04-14 2006-08-29 Inhale Therapeutic Systems, Inc. Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US7628978B2 (en) 1997-09-29 2009-12-08 Novartis Pharma Ag Stabilized preparations for use in metered dose inhalers
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
US6987076B1 (en) 1998-09-15 2006-01-17 The Morgan Crucible Company Plc Bonded fibrous materials
US6102896A (en) * 1999-09-08 2000-08-15 Cambridge Biostability Limited Disposable injector device
US6861381B1 (en) 1999-09-10 2005-03-01 The Morgan Crucible Company Plc High temperature resistant saline soluble fibres
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US6623762B2 (en) 2001-02-16 2003-09-23 Cambridge Biostability Ltd. Composition and method for controlled release injections
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside
US7153796B2 (en) 2002-01-04 2006-12-26 The Morgan Crucible Company Plc Saline soluble inorganic fibres
US7470641B2 (en) 2002-01-04 2008-12-30 The Morgan Crucible Company Plc Saline soluble inorganic fibres
US8883830B2 (en) 2003-06-20 2014-11-11 Afgin Pharma LLC. Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions
US8486439B2 (en) 2007-03-01 2013-07-16 Bioneedle Technologies Group B.V. Parenteral formulation
WO2011048379A2 (fr) 2009-10-21 2011-04-28 Innovata Limited Composition
WO2012159632A1 (fr) * 2011-05-26 2012-11-29 Vestergaard Frandsen Sa Verre fritté destiné à la libération de nutriments ou d'autres agents
WO2022237993A1 (fr) * 2021-05-14 2022-11-17 Bimeda Animal Health Limited Article de type bolus soluble dans l'eau ou dispersible dans l'eau contenant du bromoforme
WO2022237992A1 (fr) * 2021-05-14 2022-11-17 Bimeda Animal Health Limited Bolus rumen en verre soluble dans l'eau

Also Published As

Publication number Publication date
AU5414990A (en) 1990-11-05

Similar Documents

Publication Publication Date Title
WO1990011756A1 (fr) Systeme vitre a liberation lente
US4517006A (en) Composite materials comprising water-soluble glass particles
US4793474A (en) Controlled delivery agricultural capsule and method of making
US4401456A (en) Controlled release of bioactive materials using alginate gel beads
Mogul et al. Controlled release of biologically active agents for purposes of agricultural crop management
US5484600A (en) Insecticidal composite timed released particle
US5468716A (en) Bicarbonate fungicide product with a combination of surfactant ingredients
JP2875888B2 (ja) 殺虫・殺菌剤
JP3448906B2 (ja) 徐放化薬剤組成物
JPS59206301A (ja) 有害生物防除組成物
GB2077585A (en) Sustained-release bodies of soluble glass tubules
EP0901323B1 (fr) Polyamino acide favorisant l'absorption d'insecticides
EP0080330A2 (fr) Masses complexes
HU185203B (en) Composition containing toxic compounds usable safely
EP0775440B1 (fr) Preparation chimique a usage agricole et son procede de production
US5145674A (en) Biologically-active compounds comprising a biologically-active anionic portion and a water-insoluble, inorganic cationic portion
JP3021287B2 (ja) 砂場用抗菌剤
JPH11236301A (ja) 被覆農薬粒剤とそれを用いた農作物の栽培方法、及び植物根の誘引方法
US4866097A (en) Controlled release system
US2997423A (en) Method of making a composition of sodium carboxymethyl dextran and an antibiotic
Emmerich Tebuthiuron-environmental concerns.
JPS63198602A (ja) 土の中に存在する有害生物を抑制するための無毒化された有害生物防除樹脂組成物およびそれを調製する方法
CN117941704A (zh) 一种高塔复合药肥及其制备方法和应用
CN1068170C (zh) 一种防治植物病害的药膜胶悬剂
CN119184077A (zh) 一种同时可以喷雾、喷粉和烟熏的农药剂型

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI JP NO SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载